Genmab A/S
GNMSF
$249.00
-$0.45-0.18%
OTC PK
| 03/31/2026 | 12/31/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 61.17% | 61.17% | 46.06% |
| Total Depreciation and Amortization | -- | -- | 15.38% | 23.75% | 7.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -209.34% | -209.34% | -21.21% |
| Change in Net Operating Assets | -- | -- | -145.25% | -145.25% | 35.90% |
| Cash from Operations | -- | -- | 9.77% | 9.77% | 49.63% |
| Capital Expenditure | -- | -- | -30.34% | -30.34% | 15.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 95.35% | 95.35% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -80.79% | -80.79% | 259.23% |
| Cash from Investing | -- | -- | 96.83% | 96.83% | -239.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 49.64% | 49.64% | 68.94% |
| Issuance of Common Stock | -- | -- | -12.30% | -12.30% | -62.31% |
| Repurchase of Common Stock | -- | -- | -38.05% | -38.05% | -470.95% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 8.39% | 8.39% | -511.65% |
| Foreign Exchange rate Adjustments | -- | -- | 145.62% | 145.62% | 136.36% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 157.19% | 157.19% | -304.40% |